Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2014 Aug 7;25(1):100–107. doi: 10.1016/j.numecd.2014.07.006

Table 1.

Characteristics of the study participants in six body size phenotypes according to ATP III criterion

Metabolically healthy
P* Metabolically abnormal
p* P for interaction
BMI < 23 kg/m2 BMI 23-27.4 kg/m2 BMI ≥ 27.5 kg/m2 BMI < 23 kg/m2 BMI 23-27.4 kg/m2 BMI ≥ 27.5 kg/m2
n 2464 968 106 ... 1092 2251 884 ... ...
Male (%) 48.5 48.8 47.2 0.9500 43.0 47.9 44.2 0.4332 0.2050
Current smokers, % 30.7 28.5 26.4 0.1368 27.3 27.5 21.6 0.0070 0.5191
Current drinkers, % 12.3 13.8 13.2 0.2718 14.3 14.9 12.0 0.1830 0.6360
Less than primary school, % 40.8 38.2 37.7 0.2560 55.2 45.9 49.8 <.0001 0.0450
Coronary heart disease, % 1.7 2.0 2.8 0.5301 4.7 4.1 4.2 0.0426 0.9735
Stroke, % 0.7 0.6 0.9 0.8969 2.2 2.0 1.6 0.3362 0.8024
Glucose lowering medications, % 0.2 0.1 0.0 0.4413 2.5 4.0 6.7 <.0001 0.2998
Hypertension, % 1.9 8.6 11.9 <.0001 33.1 37.5 49.6 <.0001 <.0001
Diabetes, % 1.0 1.0 1.9 0.6056 12.7 11.9 19.0 0.0002 0.9534

Data are percentages.

*

P for trend across BMI categories within metabolic risk factor category

P for interaction terms (BMI × metabolic risk factor status) were assessed by logistic regression analysis.